Table 2.
Prevalence of hepatitis C virus in the Caribbean in 2010, by country *.
| Country | Location | Anti-HCV Antibodies (%) | Absolute No. Infected ** |
|---|---|---|---|
| Grenada | Lesser Antilles | 5.0 | 5150 |
| Haiti | Lesser Antilles | 4.4 | 448,272 |
| Trinidad and Tobago | Lesser Antilles | 3.9 | 50,583 |
| St Kitts and Nevis | Lesser Antilles | 2.2 | 1232 |
| Cuba | Greater Antilles | 1.8 | 202,842 |
| St Vincent and the Grenadines | Lesser Antilles | 1.0 | 1180 |
| Bahamas | Lesser Antilles | 0.75 | 2250 |
| Barbados | Lesser Antilles | 0.75 | 2100 |
| Dominica | Lesser Antilles | 0.75 | 593 |
| Dominican Republic | Greater Antilles | 0.75 | 66,713 |
| Guyana | Lesser Antilles | 0.75 | 5633 |
| Jamaica | Greater Antilles | 0.75 | 20,250 |
| St Lucia | Lesser Antilles | 0.75 | 1232 |
* The available prevalence is shown for respective Caribbean countries based on published data adapted from Lavenchy 2011. The seroprevalence of HCV antibodies across the region varied from 0.75% to 5.0%. ** Indicates absolute number of persons that were found to be seropositive for HCV antibodies.